Perritt Capital Management’s ImmuCell ICCC Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-27,026	Closed	-$144K	–	344
2023 Q3	$144K	Hold	27,026	–	–	0.08%	160
2023 Q2	$135K	Sell	27,026 -2,649	-9%	-$13.2K	0.07%	171
2023 Q1	$152K	Sell	29,675 -325	-1%	-$1.66K	0.08%	163
2022 Q4	$183K	Sell	30,000 -6,494	-18%	-$39.6K	0.1%	158
2022 Q3	$273K	Hold	36,494	–	–	0.17%	127
2022 Q2	$317K	Hold	36,494	–	–	0.19%	126
2022 Q1	$352K	Sell	36,494 -3,506	-9%	-$33.8K	0.19%	125
2021 Q4	$320K	Sell	40,000 -10,000	-20%	-$80K	0.17%	141
2021 Q3	$468K	Hold	50,000	–	–	0.26%	109
2021 Q2	$475K	Sell	50,000 -5,000	-9%	-$47.5K	0.25%	116
2021 Q1	$530K	Hold	55,000	–	–	0.29%	98
2020 Q4	$327K	Sell	55,000 -5,000	-8%	-$29.7K	0.2%	127
2020 Q3	$326K	Hold	60,000	–	–	0.24%	114
2020 Q2	$284K	Sell	60,000 -10,000	-14%	-$47.3K	0.21%	122
2020 Q1	$265K	Sell	70,000 -26,900	-28%	-$102K	0.22%	125
2019 Q4	$499K	Sell	96,900 -23,100	-19%	-$119K	0.24%	119
2019 Q3	$668K	Sell	120,000 -10,000	-8%	-$55.7K	0.28%	105
2019 Q2	$845K	Sell	130,000 -23,000	-15%	-$150K	0.33%	93
2019 Q1	$972K	Sell	153,000 -1,300	-0.8%	-$8.26K	0.36%	82
2018 Q4	$1.09M	Hold	154,300	–	–	0.42%	73
2018 Q3	$1.29M	Hold	154,300	–	–	0.39%	77
2018 Q2	$1.05M	Hold	154,300	–	–	0.31%	93
2018 Q1	$1.25M	Hold	154,300	–	–	0.36%	86
2017 Q4	$1.36M	Buy	154,300 +20,500	+15%	+$180K	0.38%	84
2017 Q3	$870K	Buy	133,800 +2,859	+2%	+$18.6K	0.23%	124
2017 Q2	$960K	Buy	130,941 +7,427	+6%	+$54.5K	0.25%	113
2017 Q1	$683K	Buy	123,514 +23,514	+24%	+$130K	0.17%	137
2016 Q4	$595K	Buy	100,000 +17,371	+21%	+$103K	0.14%	134
2016 Q3	$639K	Buy	82,629 +50	+0.1%	+$387	0.16%	136
2016 Q2	$570K	Hold	82,579	–	–	0.15%	141
2016 Q1	$566K	Buy	+82,579	New	+$566K	0.14%	141